| SCHRODER ISF JAPANESE EQUITY C ACC EUR | RVI JAPÓN | 28,14% | 52,36% | 39,13% | 104,20% |
| AB SICAV I-US VALUE PORTFOLIO I EUR | RVI USA VALOR | 28,13% | · | · | · |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO R (SNAP) USD DIS | RVI USA SMALL/MID CAP | 28,13% | 72,67% | 66,56% | 188,34% |
| INVESCO ASIAN EQUITY A CAP EUR | RVI ASIA EX-JAPÓN | 28,13% | 64,53% | 67,44% | · |
| PRIVILEDGE - ROBECO EMERGING MARKETS EQUITIES BETA ENHANCED (EUR) P CAP SYST. HDG | RVI EMERGENTES | 28,13% | · | · | · |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO E H EUR CAP | RVI JAPÓN | 28,12% | 82,17% | 101,80% | 231,56% |
| JPM EMERGING MARKETS SUSTAINABLE EQUITY D (ACC) EUR | RVI EMERGENTES | 28,12% | 58,25% | 27,17% | · |
| POLAR CAPITAL ASIAN STARS SX USD CAP | RVI ASIA PACÍFICO | 28,12% | · | · | · |
| SCHRODER GAIA BLUETREND C ACC GBP (HEDGED) | RENT. ABSOLUTA. | 28,12% | 5,05% | 23,51% | 41,96% |
| MIRAE ASSET ESG ASIA SECTOR LEADER EQUITY FUND R EUR HEDGED CAP | RVI ASIA EX-JAPÓN | 28,11% | 80,03% | 34,83% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | RVI BIOTECNOLOGÍA | 28,10% | 72,90% | 53,63% | · |
| SABADELL BOLSAS EMERGENTES, FI CARTERA | RVI EMERGENTES | 28,10% | 63,64% | 52,13% | 149,25% |
| SCHRODER ISF EMERGING MARKETS A ACC EUR (HEDGED) | RVI EMERGENTES | 28,10% | 90,69% | 32,37% | 89,74% |
| DWS ESG AKKUMULA TFC | RVI GLOBAL | 28,09% | 70,68% | 85,63% | · |
| DWS INVEST BRAZILIAN EQUITIES TFC | RVI BRASIL | 28,09% | 32,36% | 54,88% | · |
| JPM EMERGING MARKETS EQUITY A (ACC) EUR (HEDGED) | RVI EMERGENTES | 28,09% | 71,76% | 10,87% | 79,54% |
| MEDIOLANUM PACIFIC COLLECTION LH-A | RVI ASIA PACÍFICO | 28,09% | 71,38% | 48,22% | 116,78% |
| CAPITAL GROUP NEW ECONOMY FUND (LUX) BL EUR | RVI GLOBAL CRECIMIENTO | 28,08% | 92,91% | 71,51% | · |
| DWS INVEST BRAZILIAN EQUITIES FC | RVI BRASIL | 28,08% | 32,34% | 54,91% | 187,49% |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO IO ACC SGD (LONG EUROPEAN CCY VS EUR) | RVI EUROPA | 28,08% | · | · | · |
